144 related articles for article (PubMed ID: 21233859)
1. Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.
Reed SD; Li S
Cancer Gene Ther; 2011 Apr; 18(4):265-74. PubMed ID: 21233859
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.
Cutrera J; King G; Jones P; Kicenuik K; Gumpel E; Xia X; Li S
Curr Gene Ther; 2015; 15(1):44-54. PubMed ID: 25429465
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile.
Zhao Q; Hu J; Mitra A; Cutrera J; Zhang W; Zhang Z; Yan J; Xia X; Mahadeo KM; Livingston JA; Gorlick R; Li S
J Immunother Cancer; 2019 Jun; 7(1):154. PubMed ID: 31208461
[TBL] [Abstract][Full Text] [Related]
4. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
[TBL] [Abstract][Full Text] [Related]
6. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
7. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status.
Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G
DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site.
Li S; Zhang X; Xia X; Zhou L; Breau R; Suen J; Hanna E
Gene Ther; 2001 Mar; 8(5):400-7. PubMed ID: 11313817
[TBL] [Abstract][Full Text] [Related]
9. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
10. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
11. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.
Yamashita YI; Shimada M; Hasegawa H; Minagawa R; Rikimaru T; Hamatsu T; Tanaka S; Shirabe K; Miyazaki JI; Sugimachi K
Cancer Res; 2001 Feb; 61(3):1005-12. PubMed ID: 11221826
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model.
Heller L; Merkler K; Westover J; Cruz Y; Coppola D; Benson K; Daud A; Heller R
Clin Cancer Res; 2006 May; 12(10):3177-83. PubMed ID: 16707618
[TBL] [Abstract][Full Text] [Related]
13. The promising alliance of anti-cancer electrochemotherapy with immunotherapy.
Calvet CY; Mir LM
Cancer Metastasis Rev; 2016 Jun; 35(2):165-77. PubMed ID: 26993326
[TBL] [Abstract][Full Text] [Related]
14. Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation.
Heller R; Schultz J; Lucas ML; Jaroszeski MJ; Heller LC; Gilbert RA; Moelling K; Nicolau C
DNA Cell Biol; 2001 Jan; 20(1):21-6. PubMed ID: 11242540
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Application of in vivo electroporation to cancer gene therapy.
Tamura T; Sakata T
Curr Gene Ther; 2003 Feb; 3(1):59-64. PubMed ID: 12553536
[TBL] [Abstract][Full Text] [Related]
17. IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.
Zhu S; Lee DA; Li S
J Immunol; 2010 Mar; 184(5):2348-54. PubMed ID: 20139275
[TBL] [Abstract][Full Text] [Related]
18. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.
Leonard JP; Sherman ML; Fisher GL; Buchanan LJ; Larsen G; Atkins MB; Sosman JA; Dutcher JP; Vogelzang NJ; Ryan JL
Blood; 1997 Oct; 90(7):2541-8. PubMed ID: 9326219
[TBL] [Abstract][Full Text] [Related]
19. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
